Dr. Reddy’s Suspends Global Sales of Ranitidine

Drug Industry Daily
A A
Dr. Reddy’s has become the latest company to halt worldwide sales of the heartburn medication ranitidine as multiple regulatory authorities continue to investigate reports of the probable carcinogen, NDMA, in the products.

To View This Article:

Login

Subscribe To Drug Industry Daily